Statistics
Publications
31
Citations
2.7K
H-Index
24
Active since
1988
Matthew J. Martin is an author at AstraZeneca (United Kingdom) specializing in oncology, molecular oncology, and medicine.
Publications per year
1988–2024
31
31
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
Franziska Baenke, Barbara Chaneton, Matthew Smith et al. · Molecular Oncology · 2015 · 191 citations · Full text
Medicine, Cancer Biology, Oncology +17
Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A
Matthew J. Martin, Robert Hayward, Amaya Virós et al. · Cancer Discovery · 2012 · 144 citations · Full text
Medicine, Oncology, Pharmacology +17
Nicolas Floc’h, Matthew J. Martin, Jonathan W. Riess et al. · Molecular Cancer Therapeutics · 2018 · 111 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 31